Study | n | Comparison | End points | Follow-up period (months) | Results |
---|---|---|---|---|---|
Abbott et al. 2003
33
Randomised study |
55 | Radiofrequency ablation vs. Thermal balloon (Cavaterm) | Amenorrhoea rate after 12 months Pain 4 hours postoperatively |
12 (postop.) | Amenorrhoea: 43% vs. 12% (p = 0.04) Pain 48% vs. 78% (p = 0.01) |
Bongers et al. 2004
29
Kleijn et al. 2008 30 Randomised study |
126 | Radiofrequency ablation vs. Thermal balloon (Thermachoice) | Amenorrhoea rate Patent satisfaction | 12 (postop.) | Amenorrhoea: 43% vs. 8% (p < 0.001) Satisfaction 90% vs. 79% (p = 0.003) |
Amenorrhoea rate Hysterectomy rate Quality of life |
60 (postop.) | Amenorrhoea: 48% vs. 23% (p < 0.001) Hysterectomy rate 9.9% vs. 12.9%, HR 1.2 Quality of life same (p = 0.73) |
|||
Clark et al. 2011
17
Randomised study |
81 | Radiofrequency ablation vs. Thermal balloon | Amenorrhoea Duration of surgery |
6 (postop.) | Amenorrhoea 39% vs. 21% (p = 0,1) Duration of RF on average 6.2 min shorter (p < 0.001) |
Penninx et al. 2016
34
Randomised study |
104 | Comparison of bipolar radiofrequency ablation vs. Thermal balloon (Thermablate) | Amenorrhoea rate Patient satisfaction Repeat intervention rate |
12 (postop.) | Amenorrhoea rate 56% vs. 23%, RR 0.6, 95% CI 0.4 – 0.8 Patient satisfaction 87% vs. 69%, RR 0.44, 95% CI 0.2 – 0.97 Repeat intervention rate 10% vs. 12%, RR 1.02, 95% CI 0.9 – 1.2 |
Penninx et al. 2011
35
Randomised study |
160 | Radiofrequency ablation vs. Hydrothermal ablation | Amenorrhoea rate Repeat interventions | 60 (postop.) | Amenorrhoea 55,4% vs. 35,3%, RR 1,5, 95% CI 1,05 – 2,3 Repeat interventions 17% vs. 48%, RR 0.43, 95% CI 0.23 – 0.80 |
Muller et al. 2015
36
Retrospective study |
505 | Radiofrequency ablation (289 pat.) vs. Thermal balloon (ThermaChoice) (216 pat) | Amenorrhoea rate Hysterectomy rate |
35 (Median) | Amenorrhoea 45% vs. 27% (p = 0.001) Hysterectomy rate 13% vs. 19% (p = 0.066) |
Ferguson et al. 2015
37
Retrospective study |
1994 | Hysterectomy rate following radiofrequency ablation | Hysterectomy rate | 48 (Median) | Hysterectomy in 203 pat. (10%) Indication: bleeding 117 (58%); pain 31 (15%), bleeding and pain 45 (22%), other 10 (5%) |
Wyatt et al. 2016
38
Retrospective study |
144 | Dysmenorrhoea rate before and after bipolar radiofrequency ablation | Dysmenorrhoea rate | 72 (Median) | Pretherapeutic 69%; post-therapeutic 38% (p < 0.001) |
Shazly et al. 2016
28
Retrospective study |
1178 | Predictors for failure of the radiofrequency ablation | Failure: Hysterectomy or repeat ablation or drug-based ovarian suppression | 52 (Median) | Hysterometer > 10.5 cm; HR 2.58 (p = 0.006) Cavity length > 6 cm; HR 2.06 (p = 0.002) Cavity width > 4.5 cm; HR 2.06 (p = 0.002) Cavity surface > 25 cm 2 ; HR 2.02 (p = 0.003) Surgical time < 93 s; HR 2.61 (p = 0.01) |
Present study Prospective study |
187 | Predictors for failure of the radiofrequency ablation | Spotting, amenorrhoea rate, hysterectomy rate | 17,5 (Median) | Spotting, amenorrhoea rate: intramural mass, age ≤ 45 years: HR 3.699 (p = 0.036), 95% CI 1.089 – 12.570 Hysterectomy rate: intramural mass, age ≤ 45 years: HR 7.873 (p = 0.033), 95% CI 1.176 – 52.701 |